Dorsal Root Ganglion Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Dorsal root ganglion (DRG) neurons are primary sensory neurons whose cell bodies reside in the dorsal root ganglia along the spinal column. These pseudounipolar neurons transmit somatosensory information from peripheral receptors to the central nervous system and exhibit selective vulnerability in diabetic neuropathy, chemotherapy-induced peripheral neuropathy, and certain hereditary sensory disorders.
| Property | Value |
|---|---|
| Cell Type Name | Dorsal Root Ganglion (DRG) Neurons |
| Allen Atlas ID | Dorsal root ganglion, sensory neurons |
| Lineage | Neural crest > Sensory neuron > DRG neuron |
| Marker Genes | P2RX3, SCN10A, SCN11A, TRPV1, NF200 (NEFH), CGRP (CALCA), IB4 (LECT1) |
| Brain Regions | Dorsal root ganglia (C2-S5), trigeminal ganglion |
DRG neurons have a unique pseudounipolar morphology:
DRG neurons are classified by:
| Type | Marker | Function |
|---|---|---|
| Peptidergic C-fibers | CGRP, TRPV1 | Thermal/pain, neurogenic inflammation |
| Non-peptidergic C-fibers | IB4 (lectin) | Mechanical/pain |
| Aδ fibers | NF200, CGRP | Sharp pain, cold |
| Aβ fibers | NF200, P2RX3 | Touch, vibration, proprioception |
| Aβ low-threshold mechanoreceptors | NF200, S100β | Gentle touch |
DRG neurons transmit diverse somatosensory information:
Pain and Temperature
Touch and Pressure
Proprioception
| Fiber Type | Conduction Velocity | Myelination | Function |
|---|---|---|---|
| Aβ | 35-75 m/s | Heavily | Touch, pressure |
| Aδ | 5-35 m/s | Thinly | Sharp pain, cold |
| C | 0.5-2 m/s | Unmyelinated | Dull pain, warmth |
DRG neurons are early targets in diabetes:
Single-cell RNA sequencing reveals DRG diversity:
| Drug/Target | Application | Status |
|---|---|---|
| Lidocaine | Sodium channel blocker | Approved |
| Capsaicin (8%) | TRPV1 agonist | Approved (post-herpetic neuralgia) |
| Qutenza | High-concentration capsaicin patch | Approved |
| Pregabalin/Gabapentin | Calcium channel α2δ subunit | Approved |
| Duloxetine | SNRI | Approved (diabetic neuropathy) |
| NGF antibodies | Anti-NGF | Clinical trials |
| Nav1.7/1.8 blockers | Sodium channel selective | Clinical trials |
The study of Dorsal Root Ganglion Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Feldman EL, Callaghan BC, Pop-Busui R, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019;5(1):41. PMID:31147553
Staff NP, Cavaletti G, Islam B, et al. Chemotherapy-induced peripheral neurotoxicity: a summary of the symptom etiology and management approaches. Phys Med Rehabil Clin N Am. 2021;32(2):245-256. PMID:33781443
Uceyler N, Ziegler D, Sommer C. Pain in diabetic neuropathy: from epidemiology to therapy. Nat Rev Endocrinol. 2023;19(11):662-674. PMID:37528184
Waxman SG, Dib-Hajj SD. Erythermalgia: molecular basis for inherited pain disorders. Ann Neurol. 2005;58(2):169-178. PMID:16049972
Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain. Cell. 2009;139(2):267-284. PMID:19837037
Dubin AE, Patapoutian A. Nociceptors: the sensors of the pain pathway. J Clin Invest. 2010;120(11):3760-3772. PMID:21041958
7., Gold MS. Price TJ From mechanism to cure: renewing the goal to eliminate the disease of chronic pain. Nat Rev Neurol. 2023;19(1):39-50. PMID:36376327